Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000283988 | SCV000343574 | uncertain significance | not provided | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000644991 | SCV000766727 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2021-04-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) referred for clinical testing for limb-girdle muscular dystrophy (PMID: 30564623). ClinVar contains an entry for this variant (Variation ID: 289247). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with arginine at codon 345 of the CAPN3 protein (p.Pro345Arg). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and arginine. |
Natera, |
RCV000644991 | SCV002085497 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2020-12-03 | no assertion criteria provided | clinical testing |